YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1α and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cells-Reference-Cited by-同舟云学术

YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1α and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cells

Published:2020-05 Issue: Volume:874 Page:172961
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Hu Hui,Miao Xiao-Kang,Li Jing-Yi,Zhang Xiao-Wei,Xu Jing-Jie,Zhang Jing-Ying,Zhou Tian-Xiong,Hu Ming-Ning,Yang Wen-Le,Mou Ling-Yun

Funder

National Natural Science Foundation of China

NSFC

the Program for Chang-jiang Scholars and Innovative Research Team in University

Central

Publisher

Elsevier BV

Subject

Pharmacology

Reference58 articles.

1. Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated by cathepsin B;Authier;J. Biol. Chem.,1999

2. Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome;Bao;J. Biol. Chem.,2000

3. PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells;Bazzani;Oncotarget,2018

4. Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival;Brabender;Clin. Canc. Res.,2001

5. Molecular mechanisms that regulate epidermal growth factor receptor inactivation;Ceresa;Clin. Med. Oncol.,2008

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cell line models to study tyrosine kinase inhibitors in non-small cell lung cancer with mutations in the epidermal growth factor receptor: A scoping review;Critical Reviews in Oncology/Hematology;2024-02

2. Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis;Frontiers in Pharmacology;2024-01-24

3. HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies;Genes & Diseases;2024-01

4. Efficient targeting of HIF-1α mediated by YC-1 and PX-12 encapsulated niosomes: potential application in colon cancer therapy;Journal of Biological Engineering;2023-09-25

5. Targeted therapy for non‐small‐cell lung cancer: New insights into regulated cell death combined with immunotherapy;Immunological Reviews;2023-09-08